Event Brief
Eli Lilly partners with Insilico for AI drug development
Filed: Mar 30, 2026 at 7:05 AM ET
Summary: Eli Lilly has secured a deal with Insilico Medicine for AI-driven drug discovery worth up to €2.39 billion.
WHO: Eli Lilly
WHAT: partnership for AI-designed drug development
WHEN: Mar 30, 2026 at 6:46 AM ET
WHERE: USA
WHY: to accelerate the discovery and development of novel therapeutics
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →